Topical NSAID – Combines 1.5% diclofenac sodium with the transdermal drug carrier dimethyl sulfoxide (DMSO)
- Signs and symptoms of osteoarthritis of the knee
- Low systemic exposure
- Only topical with demonstrated equivalent efficacy to oral NSAIDs
- Marketed in Canada by Paladin Labs Inc. and by distributors in Greece, Italy and the U.K.